These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


122 related items for PubMed ID: 11855570

  • 1. Lack of evidence for fibrosing colonopathy by 5-ASA in humans.
    Bakowski MT, Prescott P.
    Dig Dis Sci; 2002 Feb; 47(2):469. PubMed ID: 11855570
    [No Abstract] [Full Text] [Related]

  • 2. Drug-induced fibrosing colonopathy in inflammatory bowel disease after 5-ASA?
    Allgayer H, Böhne P, Kruis W.
    Dig Dis Sci; 1999 Aug; 44(8):1600. PubMed ID: 10492139
    [No Abstract] [Full Text] [Related]

  • 3. Adult fibrosing colonopathy associated with mesalazine treatment.
    Gaia E, Sambatoro A, De Giuli P, Angeli A.
    Am J Gastroenterol; 2001 Aug; 96(8):2508-9. PubMed ID: 11513205
    [No Abstract] [Full Text] [Related]

  • 4. Lack of evidence for fibrosing colonopathy by 5-ASA in humans.
    Borum ML, Ginsberg AL.
    Dig Dis Sci; 1999 Jul; 44(7):1494. PubMed ID: 10489937
    [No Abstract] [Full Text] [Related]

  • 5. Pancreatic enzymes and Fibrosing Colonopathy.
    Dodge JA.
    J Cyst Fibros; 2015 Jan; 14(1):153. PubMed ID: 25242743
    [No Abstract] [Full Text] [Related]

  • 6. Hypersensitivity to 5-ASA suppositories.
    Weidenhiller M, Raithel M, Hahn EG.
    Dig Dis Sci; 1999 Dec; 44(12):2552-3. PubMed ID: 10630512
    [No Abstract] [Full Text] [Related]

  • 7. Mesalamine-associated hypersensitivity myocarditis in ulcerative colitis.
    Stelts S, Taylor MH, Nappi J, Van Bakel AB.
    Ann Pharmacother; 2008 Jun; 42(6):904-5. PubMed ID: 18430794
    [No Abstract] [Full Text] [Related]

  • 8. Fibrosing colonopathy associated with treatment with enteric-coated mesalazine pills.
    Prieto G, Pérez-Moneo B, Molina M, Ramos E, Sarría J, Larrauri J, Tovar JA.
    Inflamm Bowel Dis; 2009 Oct; 15(10):1452-3. PubMed ID: 19097230
    [No Abstract] [Full Text] [Related]

  • 9. Mesalamine-induced hypersensitivity pneumonitis. A case report and review of the literature.
    Sviri S, Gafanovich I, Kramer MR, Tsvang E, Ben-Chetrit E.
    J Clin Gastroenterol; 1997 Jan; 24(1):34-6. PubMed ID: 9013348
    [Abstract] [Full Text] [Related]

  • 10. Pancreatic enzymes and fibrosing colonopathy.
    van Velzen D.
    Lancet; 1999 Jul 17; 354(9174):250-1. PubMed ID: 10421324
    [No Abstract] [Full Text] [Related]

  • 11. Comparative and experimental pathology of fibrosing colonopathy.
    van Velzen D, Ball LM, Dezfulian AR, Southgate A, Howard CV.
    Postgrad Med J; 1996 Mar 17; 72 Suppl 2():S39-48; discussion S49-51. PubMed ID: 8869182
    [Abstract] [Full Text] [Related]

  • 12. Mesalamine-induced fever: an important reminder to prescribers.
    Bain JA.
    J Gastrointestin Liver Dis; 2015 Jun 17; 24(2):259. PubMed ID: 26114191
    [No Abstract] [Full Text] [Related]

  • 13. Bone marrow suppression in the setting of normal thiopurine methyltransferase phenotype testing.
    Best C, Sudel B.
    Clin Pediatr (Phila); 2010 Sep 17; 49(9):901-3. PubMed ID: 19420179
    [No Abstract] [Full Text] [Related]

  • 14. Desensitization treatment of an aspirin- and mesalamine-sensitive patient with Crohn's disease.
    Paraskevopoulos I, Konstantinou G, Liatsos C.
    Inflamm Bowel Dis; 2005 Apr 17; 11(4):417-8. PubMed ID: 15803034
    [No Abstract] [Full Text] [Related]

  • 15. A Case of Right-Sided Ulcerative Colitis with Mesalamine-Induced Hypersensitivity Reactions.
    Hirono H, Watanabe K, Hasegawa K, Honma T, Ajioka Y, Ohkoshi S.
    Am J Case Rep; 2018 May 31; 19():623-629. PubMed ID: 29849018
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Mesalamine-induced hypersensitivity pneumonitis].
    Zamir D, Weizman J, Zamir C, Fireman Z, Weiner P.
    Harefuah; 1999 Jul 31; 137(1-2):28-30, 87, 86. PubMed ID: 10959271
    [Abstract] [Full Text] [Related]

  • 18. Mesalamine (5-aminosalicylic acid) therapy well tolerated in a patient with aspirin hypersensitivity and ulcerative colitis.
    Murphy SJ, Mayer L, Abreu MT.
    J Clin Gastroenterol; 2011 Jan 31; 45(1):83-4. PubMed ID: 20535023
    [No Abstract] [Full Text] [Related]

  • 19. 5-Aminosalicylate intolerance causing exacerbation in pediatric ulcerative colitis.
    Shimizu H, Arai K, Tang J, Hosoi K, Funayama R.
    Pediatr Int; 2017 May 31; 59(5):583-587. PubMed ID: 28063246
    [Abstract] [Full Text] [Related]

  • 20. Hypersensitivity to 5-ASA suppositories.
    Borum ML, Ginsberg A.
    Dig Dis Sci; 1997 May 31; 42(5):1076-8. PubMed ID: 9149065
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.